Stock SOTAC SOTAC PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sotac Pharmaceuticals Limited

Equities

SOTAC

INE0O2D01012

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 05:13:55 03/07/2024 pm IST 		5-day change 1st Jan Change
144 INR +9.09% Intraday chart for Sotac Pharmaceuticals Limited 0.00% +22.03%
17/05 Sotac Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
15/04 5,839,600 Equity Shares of Sotac Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 15-APR-2024. CI

Income Statement Evolution (Annual data)

Fiscal Period: Maart 2020 2021 2022 2023
Net sales 1 286 488.4 731.5 774.8
EBITDA 1 18.61 14.54 79.77 75.89
EBIT 1 4.622 -11.39 68.51 53.13
Operating Margin 1.62% -2.33% 9.37% 6.86%
Earnings before Tax (EBT) 1 3.571 -20.56 46.95 39.27
Net income 1 0.875 -23.65 28.79 22.86
Net margin 0.31% -4.84% 3.94% 2.95%
EPS 2 0.2524 -2.938 3.576 2.840
Free Cash Flow - -27.84 -10.71 -54.33
FCF margin - -5.7% -1.46% -7.01%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - 2.000 -
Announcement Date 09/02/23 09/02/23 09/02/23 11/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Maart 2020 2021 2022 2023
Net Debt 1 129 167 73.6 119
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) 6.908 x 11.48 x 0.9227 x 1.574 x
Free Cash Flow - -27.8 -10.7 -54.3
ROE (net income / shareholders' equity) - -65% 62.6% 17.4%
ROA (Net income/ Total Assets) - -2.19% 12.2% 6.1%
Assets 1 - 1,082 235.1 374.8
Book Value Per Share 2 8.820 3.100 8.230 24.20
Cash Flow per Share 2 1.230 0.3300 0.0300 12.00
Capex 1 98 31.6 35 90
Capex / Sales 34.27% 6.47% 4.79% 11.61%
Announcement Date 09/02/23 09/02/23 09/02/23 11/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
SOTAC PHARMACEUTICALS LIMITED Stock Sotac Pharmaceuticals Limited
+22.03% 17.48M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.55% 816B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+39.26% 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.83% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.15% 323B
ABBVIE INC. Stock AbbVie Inc.
+7.09% 293B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.40% 238B
ROCHE HOLDING AG Stock Roche Holding AG
+0.94% 222B
NOVARTIS AG Stock Novartis AG
+13.42% 218B
AMGEN INC. Stock Amgen Inc.
+7.87% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SOTAC Stock
  4. Financials Sotac Pharmaceuticals Limited